3 Min Read
JERUSALEM (Reuters) - Teva Pharmaceutical Industries on Wednesday said growth this year would be driven by expected sales growth in its two main branded drugs but overall the prospects for 2021 were flat versus 2020.
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz, to discuss the company s 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen
This outlook fell short of market expectations, sending shares in the world’s largest generic drugmaker down 9% in morning trade in New York.
“We see a very stable business with gradually improving margins year by year,” Chief Executive Kåre Schultz told Reuters. “We are optimistic that we will have low to mid single digit growth over the coming years.”
ODGJ di Tiwu Tewa Ende Sedot Perhatian Pater Aven, Kapolres dan Dandim
tribunnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribunnews.com Daily Mail and Mail on Sunday newspapers.
天童の出羽桜、酒蔵ランキングで世界4位 有力コンテスト受賞実績で格付け
yamagata-np.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yamagata-np.jp Daily Mail and Mail on Sunday newspapers.